You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
In this issue, guest editors bring their considerable expertise to this important topic. - Contains 20 practice-oriented topics, including metabolic syndrome associated with NASH; genetic markers and comorbidities predisposing to NASH and progressive liver disease; the role of bariatric surgery and endobariatric surgery in NASH; future treatment options and regimens for NAFLD; and more. - Provides in-depth clinical reviews on non-alcoholic steatohepatitis, offering actionable insights for clinical practice. - Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.
This book covers major knowledge and recent advance regarding portal vein thrombosis. Portal vein thrombosis, a potentially life-threatening vascular disorder of the liver, refers to the development of thrombosis within main portal vein trunk and intrahepatic portal vein branches with or without splenic and mesenteric veins. In patients with acute portal vein thrombosis, if a thrombus extends into the mesenteric veins, there is a risk of intestinal ischemia and necrosis; in patients with chronic portal vein thrombosis, portal hypertension and its complications develop. The book includes chapters on the topics of epidemiology, risk factors, diagnosis, and prognostic impact, pharmacological, interventional with surgical treatment of this disease. Concepts of early diagnosis of portal vein thrombosis and extensive assessment of its severity are fully introduced. The book is beneficial for physicians to establish standard treatment strategy, for researchers to launch creative clinical and experimental studies.
In 2018, the first genetically modified children were born. Now we have the tools to reshape the future of our species. With a pair of genetic scissors known as CRISPR, we can select the traits of our children, avoid ageing, or cure disease. With that ability comes new risks, forcing us to face hard ethical questions. Torill Kornfeldt has travelled the world to meet the people driving this research forward. She has visited fertility clinics in South Korea, oncologists in China who are experimenting on sick patients, and biohackers in the US who want to make the new technology available to everyone. In The Unnatural Selection of Our Species, she asks: How can we handle these new tools that co...
The Comprehensive Guide to Hepatitis Advances provides the most up-to-date information on all types of hepatitis in one resource. Coverage spans hepatitis in all forms (viral, alcoholic, metabolic, drug, autoimmune, etc.), showing the implications of current research in clinical practice and discussing future research directions. Discussions focus on the scientific advancements in understanding the disease process and in the treatment of different groups of hepatitis.This reference is perfect for basic science researchers in the field of hepatology; practicing gastroenterologists and hepatologists as well as primary care physicians attending to liver disease; and medical residents undergoing specialist training in gastroenterology and hepatology. - Provides comprehensive coverage of the different types of hepatitis - Highlights the most recent research findings related to different types of hepatitis and their impact on clinical care - Discusses future development specific to different types of hepatitis
This book covers the clinical aspects of hepatocellular carcinoma. This book is a compendium of papers written by experts from different parts of the world to present the most up-to-date knowledge on the clinical aspects of hepatocellular carcinoma. This book is divided into three sections: (I) Diagnosis / Differential Diagnosis; (II) Surgical Treatment; (III) Non-surgical Treatment. There are 19 chapters covering topics from novel diagnostic methods to hepatic lesions mimicking hepatocellular carcinoma, from laparoscopic liver resection to major hepatectomy without allogeneic blood transfusion, from molecular targeted therapy to transarterial radioembolization, and from local ablative thera...
The field of HCV therapeutics continues to evolve rapidly and since the World Health Organization (WHO) issued its first Guidelines for the screening care and treatment of persons with hepatitis C infection in 2014 several new medicines have been approved by at least one stringent regulatory authority. These medicines called direct-acting antivirals (DAAs) are transforming the treatment of HCV enabling regimens that can be administered orally are of shorter duration (as short as eight weeks) result in cure rates higher than 90% and are associated with fewer serious adverse events than the previous interfere on containing regimens. WHO is updating its hepatitis C treatment guidelines to provi...
*As Seen on Chris Beat Cancer A groundbreaking, comprehensive guide on managing, treating, and preventing cancer. *Introducing: The Holistic Model of the Twelve Vital Fields* It’s a sad truth of our times that one in three people will experience cancer in their lifetime. By 2040, the probability will rise to one in two. As a comprehensive guide on natural treatment, Holistic Cancer Medicine is essential reading for every cancer patient—from newly diagnosed to late stage. For those seeking to prevent the disease, it also provides key information on how to reduce your risks. As the founder and director of Germany’s leading complementary cancer clinic, Dr. Henning Saupe offers Holistic Ca...
This book aims to provide an updated information on different types of major and emerging drugs for managing liver cirrhosis and its complications, including acute gastroesophageal variceal bleeding, ascites, hepatic encephalopathy, liver failure, acute kidney injury, and portal venous thrombosis. The chapters are organized by drug class, such as anti-HBV drugs, anti-HCV drugs, anticoagulants, and antibiotics, etc. The clinical efficacy, indication, and contra-indication of the various drug therapies are discussed using supportive reference material from authoritative sources and published clinical trials. It will be an invaluable reference for physicians who are treating patients with liver cirrhosis, especially those presenting with acute life-threatening complications.